Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study
Conclusions:
Our results show that patients with a history of ICH carry a significant risk of recurrent ICH when treated with VKA anticoagulation. The risk is also present, though to a lower degree, in patients with previous posttraumatic events. All patients with a history of ICH require a careful evaluation of their thromboembolic risk to estimate the net clinical benefit of (re)starting anticoagulation with VKAs.
Source: Neurology - Category: Neurology Authors: Poli, D., Antonucci, E., Dentali, F., Erba, N., Testa, S., Tiraferri, E., Palareti, G., On behalf of the Italian Federation of Anticoagulation Clinics (FCSA) Tags: Stroke prevention, Intracerebral hemorrhage ARTICLE Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Databases & Libraries | Hemorrhagic Stroke | Hypertension | Ischemic Stroke | Neurology | Oral Cancer | Renal Failure | Statistics | Stroke | Study | Vitamins